Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-30

Clinical Trial Update: Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis [Phase 3]

View source ↗

Summary

This Phase 3 trial compares two clodronate regimens with lidocaine in postmenopausal osteoporosis over one year to evaluate efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clodronate (clodronate disodium)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED